康恩貝(600572.SH):子公司擬受讓黃蜀葵花總黃酮提取物及口腔貼片相關權益
格隆匯9月13日丨康恩貝(600572.SH)公佈,公司於2021年9月13日召開第十屆董事會第十次(臨時)會議審議通過《關於公司全資子公司受讓黃蜀葵花總黃酮提取物及口腔貼片相關權益的議案》,根據公司聚焦發展中藥大健康業務、打造浙江省中醫藥健康產業主平台的發展戰略,擬加大對重大中藥創新藥研究和二次開發的投入,同意公司全資子公司杭州康恩貝製藥有限公司(“杭州康恩貝”)出資人民幣1.00億元受讓山東省藥學科學院擁有的黃蜀葵花總黃酮提取物及黃蜀葵花總黃酮口腔貼片相關技術及研究資料、臨牀試驗批件及相關全部知識產權。
黃蜀葵花總黃酮口腔貼片功能主治:清心泄熱。用於心脾積熱所致輕型複發性口腔潰瘍,症見口腔黏膜潰瘍,局部紅腫、灼熱疼痛等;截至目前,該品種尚未取得藥品註冊批件。
按照米內網的統計,國內口腔潰瘍藥物市場(中藥+化藥)整體規模約達12億元,屬細分治療領域規模較大的藥品品類。黃蜀葵花總黃酮口腔貼片作為其中的中成藥獨家新藥,由於療效確切、安全性好、劑型獨特,具有產品差異性優勢,具備成為該領域中藥大品種的潛力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.